[1]周建华　胡　涛　陈　宇　雷　丹　陈谦学.lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系[J].中国临床神经外科杂志,2019,(03):148-150.[doi:10.13798/j.issn.1009-153X.2019.03.007]
　ZHOU Jian- hua,HU Tao,CHEN Yu,et al.Relationship of expression level of long non-coding RNA NEAT1 with prognoses in the patients with gliomas[J].,2019,(03):148-150.[doi:10.13798/j.issn.1009-153X.2019.03.007]
点击复制

lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2019年03期
页码:
148-150
栏目:
论著
出版日期:
2019-03-20

文章信息/Info

Title:
Relationship of expression level of long non-coding RNA NEAT1 with prognoses in the patients with gliomas
文章编号:
1009-153X（2019）03-0148-03
作者:
周建华　胡　涛　陈　宇　雷　丹　陈谦学
作者单位：430060 武汉，武汉大学人民医院神经外科（周建华、陈谦学）；430100 武汉，协和江北医院神经外科（胡　涛、陈　宇）；420100，武汉市汉阳医院神经外科（雷　丹）
Author(s):
ZHOU Jian- hua1; 2;  HU Tao2;  CHEN Yu2;  LEI Dan3;  CHEN Qian- xue1.
1. Department of Neurosurgery, People's Hospital, Wuhan University, Wuhan 430060, China; 2 Department of Neurosurgery, Union Jiangbei Hospital, Wuhan 430100 China; 3 Department of Neurosurgery, Wuhan Hanyang Hospital, Wuhan 420100 China
关键词:
胶质瘤; 长链非编码核糖核酸; NEAT1; 预后
Keywords:
Gliomas;  Long non-coding RNA;  NEAT1;  Prognosis;  Expression
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2019.03.007
文献标志码:
A
摘要:
目的 探讨长链非编码核糖核酸（lncRNA）NEAT1在人脑胶质瘤中的表达水平及其临床意义。方法 收集武汉大学人民医院神经外科2008年4月到2013年4月收治的65例脑胶质瘤标本及同期因颅脑手术切除的正常脑组织27例。65例胶质瘤中，WHO Ⅰ~Ⅱ级26例，Ⅲ~Ⅳ级39例。根据胶质瘤组织lncRNA NEAT1表达水平，将65例胶质瘤分成lncRNA NEAT1高表达组（n=38）和低表达组（n=27）。应用RT-PCR检测lncRNA NEAT1的表达水平，用Kaplan-Meier法进行生存分析，用多因素Cox比例风险回归模型分析lncRNA NEAT1的表达水平与病人预后关系。结果 胶质瘤组织lncRNA NEAT1的表达水平（2.893±0.296）显著高于正常人脑组织（1.000±0.297；P=0.001）。WHO Ⅰ~Ⅱ级胶质瘤lncRNA NEAT1的表达水平（2.160±0.270）显著低于WHO Ⅲ~Ⅳ级胶质瘤（3.627±0.312；P=0.005）。lncRNA NEAT1高表达组病人术后生存期明显缩短（P=0.033），术后5年累积生存率显著低于lncRNA NEAT1低表达组（P=0.033）。lncRNA NEAT1表达水平高、病理级别高、KPS评分<80分以及复发时间<3个月是影响胶质瘤病人术后预后的独立危险因素（P<0.05）。结论 lncRNA NEAT1在人脑胶质瘤组织中表达水平明显增高，其表达水平与胶质瘤病人预后显著相关。
Abstract:
Objective To study the expression level of the long non-coding RNA NEAT1 in glioma tissues and its clinical significance. Methods The levels of long on-coding RNA NEAT1 expression were determined by RT-PCR in 27 normal cerebral tissues samples and 65 gliomas tissues samples, of which, 26 were WHO grades Ⅰ~Ⅱ glioma samples and 39 WHO grades Ⅲ~Ⅳ. The survival rate in 65 patients with gliomas from whom the gliomas samples were derived was analyzed by Kaplan-Meier method and Log-rank. The factors related to the prognoses in these 65 patients with gliomas were univariate analysis and the Cox proportional risk regression model. Results The level of NEAT1 expression was significantly higher in the glioma tissues than that in the normal cerebral tissues (P<0.01). The level of the NEAT1 expression was significantly higher in the grades Ⅲ~Ⅳ gliomas tissues than that in the grades Ⅰ~Ⅱ gliomas tissues (P<0.01). The risk factors related to the prognoses in these 65 patients with gliomas included the high level of NEAT1 expression, high WHO grade, Karnofsky performance score<80 points and recurrence time <3 months. Conclusion The level of NEAT1 expression is significantly increased in the gliomas tissues compared to that in the normal cerebral tissues and is negatively correlated with the prognoses in the patients with gliomas. It is suggested that the level of NEAT1 expression in the gliomas tissues is an important index to predict the prognoses in the patients with gliomas.

参考文献/References:


[1] 孙荣辉，徐国政. VEGF、MMP-9在人脑胶质瘤中的表达及其意义[J]. 中国临床神经外科杂志，2010，15：273-277.
[2] 徐国政，袁先厚. 脑胶质瘤靶向治疗新进展[J]. 中国临床神经外科杂志，2011，16（9）：568-572.
[3] 常　骏，潘先文. 胶质瘤基因治疗进展[J]. 临床神经外科杂志，2012，9（3）：184-185.
[4] 卢耀星，杨建安，刘银河. 心血管疾病相关lncRNA调控机制的研究进展[J]. 中国动脉硬化杂志，2016，24：537-540.
[5] 潘　翔，金　露，全　晶，等. NEAT1在肾癌中的表达及其临床意义研究[J]. 临床泌尿外科杂志，2016，31（8）：706-709.
[6] 靳倩倩，孙亚男. 长链非编码RNA NEAT1在肿瘤中的研究进展[J]. 疑难病杂志，2016，15（3）：326-329.
[7] Zhang F, Wu L, Qian J, et al. Identification of the long non-coding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus [J]. J Autoi-mmun, 2016, 75: 96-104.
[8] 姚芳苡，黄自坤，熊国亮，等. 肺结核患者外周血单个核细胞中lncRNA NEAT1的检测及临床意义[J]. 实验与检验医学，2017，35（1）：5-8.
[9] Ma Y, Liu L, Yan F, et al. Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas[J]. World J Surg Oncol, 2016, 14(1): 41.
[10] Chen X, Kong J, Ma Z, et al. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prog-nosis [J]. Am J Cancer Res, 2015, 5(9): 2808-2815.
[11] 郭春芳，李华强，陈晏林. 卵巢癌患者组织中lncRNA NEAT1和CTBP2表达水平及其与临床病理特征的关系[J]. 临床和实验医学杂志，2018，17（12）：1285-1289.
[12] 周炼钢，廖　恺，周晓燕. lncRNA NEAT1对肝癌细胞凋亡的影响[J]. 齐鲁医学杂志，2017，32（5）：547-549.
[13] 罗泳林，陆爱英，蔡永林，等. 血浆长链非编码RNA NEAT1和H19及MALAT1在鼻咽癌中的表达及临床意义[J]. 中国耳鼻咽喉颅底外科杂志，2018，24：230-235.
[14] 徐红超，牟永告，周旺宁，等. 规范治疗与脑胶质瘤患者的预后[J]. 中国临床神经外科杂志，2007，12（5）：259-262.
[15] 李剑峰，陈银生，赛　克，等. 173例胶质瘤预后的影响因素分析[J]. 中国临床神经外科杂志，2016，21（）6：327-330
[16] Tramacere F, Gianicolo E, Serinelli M, et al. [Multivariate analysis of prognostic factors and survival in patients with glioblastoma multiforme] [J]. Clin Ter, 2008, 159(4): 233-238
[17] Gorlia T, van den Bent MJ, Hegi ME, et al. Nomograms for predicting survival of patients with newly diagnosed glio-blastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 [J]. Lancet Oncol, 2008, 9: 29-38.
[18] 李景林，郑汪洋，李鑫恒，等. lncRNA-CCAT1与消化道肿瘤关系的研究进展[J]. 基础医学与临床，2018，38（2）:237-240.
[19] 陈　青. GEO数据库分析长链非编码RNA SNHG6在结肠癌中的表达及临床意义[J]. 临床医学研究与实践，2018，3（17）：7-9.
[20] Yang F，Zhang L，Huo XS，et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans [J].Hepatology，2011，54（5）:1679-1689.
[21] 邢宏松，吴国俊，黎建军，等. lncRNA NEAT1对肝癌细胞增殖、迁移和侵袭的影响及其机制[J]. 临床与病理杂志，2018，38（5）：922-928.
[22] Qian K, Liu G, Tang Z, et al. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2 [J]. Arch Biochem Biophys, 2017, 615:1-9.

相似文献/References:

[1]刘骏辉　许鹏飞　杨吉安　高　论 综述　陈谦学 审校.儿童脑桥弥漫内生型胶质瘤的研究进展[J].中国临床神经外科杂志,2019,(03):178.[doi:10.13798/j.issn.1009-153X.2019.03.019]
[2]杨　智　唐　栋　曹　磊　杨光诚.血清外泌体miRNA-30a-5p在人脑胶质瘤诊断及预后评价中的作用[J].中国临床神经外科杂志,2020,(05):296.[doi:10.13798/j.issn.1009-153X.2020.05.013]
　YANG Zhi,TANG Dong,CAO Lei,et al.Value of serum exosome miRNA-30a-5p to diagnosis and prognosis evaluation of human glioma[J].,2020,(03):296.[doi:10.13798/j.issn.1009-153X.2020.05.013]
[3]许强华　陈新军　刘平非　谢　腾　陈晓巍　陈治军.TSA联合HSV-1对C6鼠胶质瘤细胞株细胞增殖、细胞凋亡的影响[J].中国临床神经外科杂志,2020,(05):299.[doi:10.13798/j.issn.1009-153X.2020.05.014]
　XU Qiang-hua,CHEN Xin-jun,LIU Pin-fei,et al.Effects of TSA combined with HSV-1 on cell proliferation and apoptosis of C6 glioma cells[J].,2020,(03):299.[doi:10.13798/j.issn.1009-153X.2020.05.014]
[4]罗志华　张严国　黄从刚　王春燕　李乾锋.lncRNA MEG3表达水平及甲基化状态与垂体腺瘤术后复发的关系[J].中国临床神经外科杂志,2020,(12):825.[doi:10.13798/j.issn.1009-153X.2020.12.003]
　LUO Zhi-hua,ZHANG Yan-guo,HUANG Cong-gang,et al.Relationship between expression level and methylation status of lncRNA MEG3 and postoperative recurrence of pituitary adenoma[J].,2020,(03):825.[doi:10.13798/j.issn.1009-153X.2020.12.003]

备注/Memo

备注/Memo:
通讯作者：陈谦学，E-mail：chenqx666@sohu.com
更新日期/Last Update: 2019-03-25